Amplify Treatments, Testing and Advancements ETF (GERM) Chart & Stock Price History $19.16 0.00 (0.00%) As of 05/16/2025 Add Compare Share Share Chart Stock AnalysisChartHoldingsBuy This Stock Amplify Treatments, Testing and Advancements ETF Stock Price Performance The Amplify Treatments, Testing and Advancements ETF (GERM) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 3.54%, with a year-to-date return of 0.00%. In the past month, the fund has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Amplify Treatments, Testing and Advancements ETF traded at $19.16 with a market cap of $10.54 million and volume of 0 shares. Receive GERM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amplify Treatments, Testing and Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month PerformanceN/A3 Month PerformanceN/AYear-To-Date PerformanceN/A1 Year Performance-3.54% GERM Stock Chart for Thursday, May, 22, 2025 GERM Chart by TradingView Amplify Treatments, Testing and Advancements ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel No price data in the selected date range. Related Companies Tema Neuroscience and Mental Health ETF Stock Price Chart YieldMax Dorsey Wright Hybrid 5 Income ETF Stock Price Chart TCW Transform Supply Chain ETF Stock Price Chart SPDR S&P SmallCap 600 ESG ETF Stock Price Chart MicroSectors FANG & Innovation -3x Inverse Leveraged ETN Stock Price Chart National Security Emerging Markets Index ETF Stock Price Chart First Trust Bloomberg Artificial Intelligence ETF Stock Price Chart Dorsey Wright Thematic ETF Stock Price Chart Ionic Inflation Protection ETF Stock Price Chart AdvisorShares Psychedelics ETF Stock Price Chart Receive GERM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amplify Treatments, Testing and Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:GERM) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Treatments, Testing and Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Treatments, Testing and Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GERM Stock Free GERM Stock Alerts